Delivery Order V797D70251-36C25919F0133
Award Date 1/3/19
Potential Completion Date 1/31/19
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84148, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 20 to Eisai Inc., a foreign-owned, for-profit manufacturer of goods. The contract is a Blanket Purchase Agreement (BPA) Call for the drug Lenvima in 10 mg, 20 mg, and 24 mg dosages, with a potential value of $236,120.69. The contract was awarded on October 1, 2017 and has a completion date of September 30, 2018. The contract was not set aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,324.32 contract is for the supply of Lenvima 10 mg daily dose 30s, a medication used in the treatment of certain types of cancer. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, SPE2DX15D9168, to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of LENVIMA 4 MG CAPSULE 30S. The contract has a ceiling value of $42,648.64 and a completion date of May 3, 2024. This award is part of a larger indefinite delivery vehicle (IDV), contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders...
- The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 daily doses of 14 mg Lenvima oral capsules. To be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, the order is to be completed by July 26, 2023 and was issued under an existing DLA pharmaceutical supply contract vehicle. No set aside designation or subcontractors were indicated. Lenvima is approved to treat types of thyroid cancer...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LENVIMA 10 MG DAILY DOSE 30S. The contract has a ceiling value of $9,910.95 and a period of performance ending on June 30, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. for the supply of the pharmaceutical product LENVIMA 10 MG DAILY DOSE 30S. The order has a ceiling value of $22,013.90 and a performance period ending on July 18, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...